Epilepsy Drugs May Avoid Black Box – WSJ.com

There may be hope for the FDA on black boxes just yet…

Epilepsy Drugs May Avoid Black Box – WSJ.com
Epilepsy Drugs May Avoid Black Box
By JARED A. FAVOLE
July 11, 2008; Page B6

BELTSVILLE, Md. — A Food and Drug Administration panel has recommended against adding the agency’s toughest warnings to labels of epilepsy drugs, saying studies didn’t show a high-enough risk for suicidal behavior to warrant such warnings.

So, the full FDA panel realizes hitting medications with a Black Box makes doctors not want to prescribe them, and said the very small increase in suicides among people taking epilepsy drugs didn’t warrant the warning.

So, if an increase in suicidality isn’t boxable, what about tendons and tendon ruptures?

Black Box Warnings now Officially Useless

FDA to Add Warning to Antibiotics – WSJ.com
By JARED A. FAVOLE
July 9, 2008; Page B7

WASHINGTON — The U.S. Food and Drug Administration will seek to add strong warnings about the risks of tendon rupture associated with a class of antibiotics used to treat bacterial infections.

The FDA wants to add black-box warnings, the strongest warning the agency issues, to a handful of drugs, including Bayer AG’s Cipro and Johnson & Johnson’s Levaquin. The move comes six months after the consumer group Public Citizen sued the FDA to require the agency to add black-box warnings to the drugs.

Serious reports of tendonitis and tendon rupture continue to increase with use of the drugs, prompting the FDA to ask companies to add the stronger warnings, the FDA said in a posting on its Web site Tuesday. Such ruptures most frequently involves the Achilles tendon, but also include ruptures of the shoulder, hand, biceps, and thumbs.
(emphasis mine)

Black box warnings used to be for very serious, life-threatening problems in drugs.  Now tendonitis and tendon rupture are life threats, or are so serious they warrant a Black Box?  The elevation of known, well-documented drug side effects to Black Box status dilutes its meaning, and will ultimately require the formation of a new class of warnings.

Tendon ruptures aren’t benign.  Neither are infections.  Name me an antibiotic that wouldn’t rate a black box under the criteria used on the flouroquinolones, then wonder at what’s happened to the FDA.